Safety and Efficacy of a Device for the Relief of Pain Due to Carpal Tunnel Syndrome

NCT ID: NCT03810326

Last Updated: 2019-01-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

40 participants

Study Classification

INTERVENTIONAL

Study Start Date

2019-01-12

Study Completion Date

2020-01-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Interventional study to evaluate efficacy and safety of an active splint.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Carpal Tunnel Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Intervention

Group Type EXPERIMENTAL

CTR device (tradename named Xtend)

Intervention Type DEVICE

Non invasive active splint

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

CTR device (tradename named Xtend)

Non invasive active splint

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Male or female patients, above 40 years of age.
* Able to understand and sign informed consent
* Pain associated with mild to moderate carpal tunnel syndrome in a single wrist
* Numbness and tingling in the median nerve distribution
* Nocturnal Numbness
* Weakness and/or atrophy of the thenar musculature
* Demonstrate positive Phalen's Test of the affected extremity
* Demonstrate positive Tinel's Test of the affected extremity
* Sensory impairment defined as a loss of 2-point discrimination
* Have recent (within 3 months) electro-diagnostic evidence of Carpal Tunnel Syndrome

Exclusion Criteria

* History of surgical carpal tunnel release
* Pregnancy
* Diabetes not controlled by medication
* Radiculopathy i.e., cervical radiculopathy, diabetic radiculopathy
* Thoracic outlet syndrome
* Compromised skin integrity
* Past history of traumatic event, surgery, or congenital impairment of the forearm, wrist, or hand
Minimum Eligible Age

40 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Yuinvent Innovations Ltd.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Tel Aviv Sourasky Medical Center

Tel Aviv, , Israel

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Israel

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Oleg Dulcart, PHd

Role: CONTACT

+972-(0)524-262544

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Oleg Dulcart

Role: primary

+9720524262544 ext. +9720524262544

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

VY-CTS1-01

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.